- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Progesterone Receptor-negative Breast Cancer in Germany
Total 545 results
-
Novartis PharmaceuticalsCompletedMelanoma | Triple Negative Breast Cancer | Endometrial Carcinoma | Pancreatic CarcinomaUnited States, Germany, Italy, Japan, Belgium, Switzerland, Korea, Republic of, Hong Kong, Finland, France, Spain
-
Merck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast NeoplasmsColombia, United States, Canada, Chile, France, Germany, Hungary, Ireland, Japan, Korea, Republic of, Poland, Spain, Taiwan, Ukraine, United Kingdom
-
Hoffmann-La RocheActive, not recruitingTriple Negative Breast NeoplasmsKorea, Republic of, Italy, China, Finland, France, Hungary, Spain, United Kingdom, Argentina, United States, Bosnia and Herzegovina, Brazil, Chile, Germany, Poland, Russian Federation, Morocco, Mexico, Portugal, Serbia, Turkey, South... and more
-
University Hospital TuebingenRecruitingAdvanced/Metastatic Breast Cancer | Breast Cancer (Early Breast Cancer)Germany
-
Tianjin Medical University Cancer Institute and...RecruitingBreast Cancer | Breast Reconstruction | Radiation | Synthetic MeshUnited States, China, Germany
-
University Hospital TuebingenRecruitingBreast Cancer | Head and Neck Cancer | Esophageal Cancer | Rectal Cancer | Prostate Cancer | Liver Cancer | OligometastasisGermany
-
Fundacao ChampalimaudEuropean Commission; Cankado GmbH; Bocconi University; INESC TEC - Institute for... and other collaboratorsRecruitingBreast CancerGermany, Israel, Italy, Portugal, Poland
-
Toralf Reimer, MD PhDEuropean Breast Cancer Reseach Association of Surgical Trialists; University... and other collaboratorsRecruitingBreast Cancer | Breast Cancer FemaleSpain, Austria, Germany, Italy
-
Hoffmann-La RocheCompleted
-
University of Erlangen-Nürnberg Medical SchoolUnknownBreast CancerAustria, Germany, Hungary, Poland, Spain
-
University Hospital Schleswig-HolsteinRecruitingMetastatic Breast CancerGermany
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenoid Cystic Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Endometrial Neoplasms | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder Carcinoma | HER2 Negative Breast Neoplasms | Hormone Receptor Positive Breast NeoplasmsUnited States, Spain, Canada, United Kingdom, Germany, Italy
-
Pierre Fabre Pharma GmbHiOMEDICO AGCompletedMetastatic Breast Cancer | Non Small Cell Lung CarcinomaGermany
-
Cohera Medical, Inc.Completed
-
Heidelberg Pharma AGU.S. Army Medical Research and Development CommandCompletedMetastatic Breast CancerUnited States, Belgium, Brazil, Germany, Israel
-
Novartis PharmaceuticalsRecruitingBreast CancerFrance, Germany, Spain, Portugal
-
Novartis PharmaceuticalsActive, not recruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Triple Negative Breast Cancer | Microsatellite Stable Colorectal CancerUnited States, Taiwan, Spain, Germany, Japan, Hong Kong
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
Queen Mary University of LondonAstellas Pharma IncUnknownPrimary Breast Cancer ER+ve | Primary Breast Cancer AR+ve TNBNGermany, United Kingdom, Spain, United States, Ireland
-
SamanTree Medical SASt. Vincenz Krankenhaus GmbH, PaderbornCompletedBreast-Conserving Surgery | Breast Cancer - Ductal Carcinoma in Situ (DCIS)Germany
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticFrance, Germany, Spain, Austria, Belgium, Slovenia, Poland, Bulgaria, United Kingdom, Italy
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
Hoffmann-La RocheRecruitingBreast CancerFinland, Italy, Spain, Germany
-
West German Study GroupMerck Sharp & Dohme LLC; NanoString Technologies, Inc.Completed
-
Eli Lilly and CompanyCompletedBreast CancerSpain, Italy, Russian Federation, Germany
-
Eisai LimitedTerminatedMetastatic Breast CancerRussian Federation, United Kingdom, Germany, Italy, Spain
-
European Organisation for Research and Treatment...TerminatedBreast CancerFrance, Belgium, United Kingdom, Slovenia, Germany
-
Allarity TherapeuticsRecruitingMetastatic Breast CancerGermany, Finland, Poland, United Kingdom, Belgium, Italy, Netherlands
-
Dompé Farmaceutici S.p.AWithdrawnFatigue | Locally Advanced or Metastatic Breast CancerUnited States, Italy, Germany
-
Cancer Trials IrelandCompletedMetastatic Breast CancerSpain, Ireland, Israel, Finland, Portugal, France, Germany, Norway
-
AIO-Studien-gGmbHNo longer availablethe Treatment Hand-foot Syndrome Patients With Gastrointestinal Tumors or Breast Cancer, Who Are Treated With CapecitabineGermany
-
West German Study GroupAgendiaRecruitingFemale Breast CancerGermany
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedBreast Cancer | Contralateral Breast CancerUnited States, Germany, Canada
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
University Hospital TuebingenUnknownMetastatic Breast CancerGermany
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
MedSIRCompletedMetastatic Breast CancerSpain, Czechia, France, Germany, Italy, Russian Federation, United Kingdom
-
ExelixisActive, not recruitingA Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (STELLAR-001)Renal Cell Carcinoma | Colorectal Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor Positive Breast Carcinoma | Neoplasm MalignantUnited States, Australia, Belgium, Czechia, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
BayerCompletedBreast Neoplasms | Breast Cancer, MetastaticGermany, Italy, Israel, Poland, Switzerland, United Kingdom, Greece
-
ExelixisActive, not recruitingRenal Cell Carcinoma | Head and Neck Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Castration-resistant Prostate Cancer | Urothelial Carcinoma | Differentiated Thyroid Cancer | Gastroesophageal... and other conditionsUnited States, Australia, Belgium, France, Germany, Italy, Netherlands, Spain, United Kingdom
-
BayerCompletedMetastatic Breast CancerSpain, Austria, United Kingdom, France, Finland, Poland, Germany, Sweden, Italy, Switzerland
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Novartis PharmaceuticalsCompletedBreast Cancer | Prostate Cancer | Bone MetastasisGermany
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
AstraZenecaCompleted
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Krebsforschung Schweiz, Bern, Switzerland; Rising Tide FoundationRecruitingLymphedema, Breast CancerSpain, Switzerland, United States, Germany, Argentina, Austria, Belgium, Brazil, Canada, Greece, Italy, Netherlands, Romania, Sweden
-
Hoffmann-La RocheCompletedBreast CancerAustralia, Spain, United Kingdom, Germany, Belgium, Italy, Finland, Netherlands